Takeda sees ixazomib combo results posted; zasocitinib Phase 2 vitiligo trial activeNov 6Weekly roundup, 4 itemsBristol Myers Squibbixazomib
Takeda's dazostinag Phase 1/2 trial completes with results; ixazomib HIV study still not recruitingOct 22Weekly roundup, 2 itemsixazomibTakeda Pharmaceutical Co LtdUpdated